Concepedia

Hyi-Man Park

HP

Statistics

Publications

5

Citations

279

H-Index

5

Active since

2008

Affiliations

Novartis (United States)(Current)

Novartis (Japan)

Hyi-Man Park is an author at Novartis (United States) specializing in pharmacology, molecular pharmacology, and molecular biology.

Publications per year

2008–2017

5

Publications

5

Small-molecule WNK inhibition regulates cardiovascular and renal function

Ken Yamada, Hyi-Man Park, Dean F. Rigel et al. · Nature Chemical Biology · 2016 · 167 citations · Full text

, , +10

Discovery and Characterization of Allosteric WNK Kinase Inhibitors

Ken Yamada, Ji-Hu Zhang, Xiaoling Xie et al. · ACS Chemical Biology · 2016 · 45 citations · Full text

, , +16

Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension Models

Ken Yamada, Julian Levell, Taeyong Yoon et al. · Journal of Medicinal Chemistry · 2017 · 37 citations · Full text

, , +17

Tumor growth inhibition by synthetic and expressed siRNA targeting focal adhesion kinase

Kae Tsutsumi, Tatsuhiko Kasaoka, Hyi-Man Park et al. · International Journal of Oncology · 2008 · 16 citations · Full text

, , +14

Regulation of expression of the mouse adiponectin gene by the C/EBP family via a novel enhancer region

Chie Koshiishi, Hyi-Man Park, Hidefumi Uchiyama et al. · Gene · 2008 · 14 citations

, , +15

1–5 of 5